Chiesi Ventures

What they do

Chiesi Ventures is a venture capital firm that invests in early stage opportunities operating in the area of rare and orphan disorders. The company funds research and development opportunities for therapies of rare diseases and aims to improve the quality of diagnosis, disease management, care and therapy to all patients affected by rare diseases. It also aims to accelerate the expansion of the Chiesi network in the U.S. among universities, venture capital investors, rare disease patient organizations, and entrepreneurial companies developing treatments for rare diseases. On September 2, 2014, Chiesi Ventures and A. M. Pappas & Associates announced a strategic collaboration. Chiesi Ventures was founded on September 2, 2014, and is headquartered in Parma, Italy with presence in the United States. It is owned by Chiesi Group.

What they look for

We create value by solving the mosaic of the many rare diseases and unlocking its huge market potential. To this end, we believe that there is a great potential in partnering on embryonic ideas from academic institutions and industrializing and scaling up a pharmaceutical product

Stage

Seed, Series A

Sectors

Healthcare

Based

Boston, US